RAPP - Company ID 0002012593
Rapport Therapeutics, Inc. trades as RAPP and has a market capitalization of $2.00 B, making it the #2138 largest US-listed company by market value. This page tracks Rapport Therapeutics, Inc. through 195 SEC filings, with financial statements and metrics updated as new reports are filed.
Research snapshot
Updated
2026-07-09
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Next research step
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.
| Filing | Type | Filed |
|---|---|---|
| Insider sale notice | 144 | 2026-05-27 |
| SCHEDULE 13G/A | - | 2026-05-15 |
| Insider trade | 4 | 2026-05-13 |
| Insider sale notice | 144 | 2026-05-11 |
| Insider trade | 4 | 2026-05-11 |
| Insider sale notice | 144 | 2026-05-08 |
| Insider sale notice | 144 | 2026-05-07 |
| Quarterly report | 10-Q | 2026-05-07 |
The largest companies sharing Rapport Therapeutics, Inc.'s SEC industry classification (pharmaceutical preparations).
Rapport Therapeutics, Inc. (RAPP) has a market capitalization of $2.00 B as of 2026-07-09, ranking #2138 among US-listed companies.
In its latest fiscal year Rapport Therapeutics, Inc. reported a net loss of $111.48M.